About Evrima
Evrima is a company based in Sydney (Australia) founded in 2018 by Charlotte Bradshaw. Evrima has raised $3 million across 1 funding round from investors including Wavemaker Partners, BridgeLane and Artesian. Evrima offers products and services including Evrilink, Evripath, and Evriquest. Evrima operates in a competitive market with competitors including PageGroup, Cloudstaff, Michael Page, HealthMatch and APM, among others.
- Headquarter Sydney, Australia
- Founders Charlotte Bradshaw
-
Sectors
HealthcareBusiness Services
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Evrima Technologies
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3 M (USD)
in 1 rounds
-
Latest Funding Round
$3 M (USD), Seed
Sep 05, 2022
-
Investors
Wavemaker Partners
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evrima
Evrima offers a comprehensive portfolio of products and services, including Evrilink, Evripath, and Evriquest.
Platform for managing clinical trial data and processes efficiently.
Tool for GPs to search and refer patients to clinical trials.
Service for recruiting diverse participants in clinical trials.
Funding Insights of Evrima
Evrima has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Seed round of $3 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Evrima
Evrima has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Wavemaker Partners, BridgeLane and Artesian.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
BridgeLane is operated as a single family office for investments.
|
Locked | Locked | Locked | |
|
Investments in early-stage technology companies are made by Wavemaker Partners.
|
Locked | Locked | Locked | |
|
Venture capital and private debt fund focused on climate, agrifood, health, AI, and multiple sectors
|
Locked | Locked | Locked |
Investor details for Evrima
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Evrima
Investment portfolio details for Evrima
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Evrima
Detailed financials for Evrima
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Evrima Comparisons
Peer comparison for Evrima
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Evrima
Evrima operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PageGroup, Cloudstaff, Michael Page, HealthMatch and APM, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Recruitment consultancy services are provided to businesses and professionals.
|
|
| Locked | Locked | Locked |
Outsourcing solutions are provided to businesses for operational efficiency.
|
|
| Locked | Locked | Locked |
Recruitment services and job searches are facilitated across UK industries.
|
|
| Locked | Locked | Locked |
Provider of patient recruitment platform
|
|
| Locked | Locked | Locked |
Outplacement, injury prevention, and assessment services are delivered to clients.
|
|
| Locked | Locked | Locked |
Offers specialized recruitment services to businesses.
|
Detailed competitors of Evrima
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Evrima
Complete news archive for Evrima
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evrima
Evrima was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Evrima is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Charlotte Bradshaw is the current CEO of Evrima. They have also founded this company.
Evrima is a funded company, having raised a total of $3M across 1 funding round to date.
Evrima was established in 2018 in Sydney, Australia, with Charlotte Bradshaw as founder and CEO. A platform is provided for identifying and enrolling in ongoing clinical trials and medical studies. The overall clinical trial process is streamlined as a result. Focus is placed on the healthcare technology sector, supporting research participants and trial coordinators across various medical fields.
Evrima's top competitors include PageGroup, Michael Page and Cloudstaff.
Evrima offers Evrilink, Evripath, and Evriquest.
Evrima has 3 investors. Key investors include Wavemaker Partners, BridgeLane, and Artesian.